Navigation Links
Polaris Group Announces Treatment of First Patient in Phase 2 Study of ADI-PEG 20 in Acute Myeloid Leukemia
Date:11/6/2013

SAN DIEGO, Nov. 6, 2013 /PRNewswire/ -- Polaris Group announced today that the first patient has been dosed in its Phase 2 trial of ADI-PEG 20, arginine deiminase formulated with polyethylene glycol, for the treatment of Relapsed/Refractory Acute Myeloid Leukemia. Polaris Group is conducting clinical trials on ADI-PEG 20 for the treatment of several other indications, including hepatocellular carcinoma. The latter indication is already in a global Phase 3 study.

(Logo: http://photos.prnewswire.com/prnh/20131106/LA12039LOGO)

"Data from our collaborators show that acute myeloid leukemia cells require the amino acid arginine for growth, and that deprivation of arginine by ADI inhibits leukemia cell growth," said John Bomalaski, M.D., Executive Vice President of Medical Affairs at Polaris Group. "Treatment options for patients who have this form of leukemia are limited. We are pleased that the first patient in this trial has been treated with ADI-PEG 20 and we hope that ADI-PEG 20 will be of benefit to patients in this trial."

About ADI-PEG 20
ADI-PEG 20 is a biologic being developed by Polaris Group to treat cancers, especially those carrying a major metabolic defect that renders such cancer cells, unlike normal cells, unable to internally synthesize arginine. Because arginine is one of the 20 amino acids that are essential for protein synthesis and survival of cells, it is believed these cancer cells become dependent upon the external supply of arginine to survive and grow. ADI-PEG 20 is designed to systemically deplete the external supply of arginine, which causes arginine-dependent cancer cells to die while leaving the normal cells unharmed. Multiple cancers have been reported to have a high degree of arginine-dependency.

About Polaris Group
Polaris Group is a privately held biopharmaceutical company
'/>"/>

SOURCE Polaris Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Demonstrates Potential Anticancer Activity in Various Metastatic Sarcomas and Bladder Cancers That Are Deficient in Key Metabolic Protein, and Enhanced Effects with Combination Therapy in Melanoma
2. GSI Group Announces Financial Results for the Third Quarter 2013
3. CAO Group Launches New Pilot Diode Laser System
4. Simcere Pharmaceutical Group to Announce Third Quarter 2013 Financial Results on Thursday, November 14, 2013
5. Novartis Group calls on FDA to maintain the well-established naming policy for all biologics to help ensure patient safety
6. InspireMDs MGuard Stent Shows Lower Mortality Rate in STEMI Patients at Twelve Months Compared to Control Group
7. Securus Medical Group Raises $6.5M, Appoints New CEO
8. Pediatric Group Offers Consistent Vision Care Across Its Network with Spot Vision Screener
9. Long Island Plastic Surgical Group (LIPSG) Nominated in Four Categories for Best of Long Island 2014 Awards
10. Private Hospital Group in Spain Expands Radiotherapy Capabilities with Countrys First Elekta Versa HD System
11. Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis to be Presented at AASLD Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Aug. 22, 2014  Medical Science Liaisons serve as ... in the healthcare sector. As the impact of technology ... changing how Medical Science Liaisons (MSLs) interact with physicians ... using the tablet to not only share important disease ... coordinate thought leader interactions across geographies and therapeutic areas. ...
(Date:8/22/2014)... 22, 2014 ... has announced the addition of the  "Global ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... instrument for any modern science laboratory as ... materials. It can be broadly classified into ...
(Date:8/22/2014)... DUBLIN , August 22, 2014 /PRNewswire/ ... ) has announced the addition of the  ... to their offering.       (Logo: ... room with a sterile environment in a ... It is equipped with technically advanced equipment, ...
Breaking Medicine Technology:iPads Enhancing Medical Science Liaison Interactions with Thought Leaders, New Study Shows 2Global Laboratory Electronic Balance Market 2014-2018: Key Vendors are A&D Company, Mettler-Toledo, Sartorius and Thermo Fisher 2Global Operating Room Equipment Market 2014-2018: Key Vendors are Getinge, STERIS, Stykron and TRUMPF Medical Systems 2
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... Letter (CRL) from the U.S. Food and Drug Administration ... for AZ-004 (Staccato® loxapine), submitted as Adusuve™ Staccato® (loxapine) ... is issued by FDA,s Center for Drug Evaluation and ...
... Ltd. (NYSE Amex: CPD ) announced today that ... Executive Officer following the resignation of Jitendra N. Doshi as ... 1, 2010, due to personal and health-related reasons. ... many contributions during his years of service to the Company, ...
Cached Medicine Technology:Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA 2Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA 3Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA 4Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA 5Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as G. P. Singh to Assume Position of CEO Effective November 1, 2010 and Update on Remediation Status 2Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as G. P. Singh to Assume Position of CEO Effective November 1, 2010 and Update on Remediation Status 3Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as G. P. Singh to Assume Position of CEO Effective November 1, 2010 and Update on Remediation Status 4
(Date:8/23/2014)... York (PRWEB) August 23, 2014 Dermatophytic ... is one of the most common fungal infections of ... appearance of the nails such as, increased opaqueness and ... specifically describes the dermatophytic invasion of the nail plates ... artificial nail is applied as the nails are abraded ...
(Date:8/23/2014)... Texas (PRWEB) August 23, 2014 ... of the function of the myocardium (the heart ... failure; common symptoms are dyspnea (breathlessness) and peripheral ... are often at risk of dangerous forms of ... most common form of cardiomyopathy is dilated cardiomyopathy. ...
(Date:8/23/2014)... Pittsburgh, PA (PRWEB) August 23, 2014 ... mess when they gave a urine sample," said an ... the entire process easier and mess-free, I came up ... Device to allow urine samples to be collected from ... added peace of mind to patients and staff. The ...
(Date:8/23/2014)... 2014 "Many men refuse to touch ... up getting covered in urine and spit," said an ... bathroom situations, I came up with this hygienic device." ... a man raises the toilet seat before urinating. The ... This reduces contact with dirt and germs. The accessory ...
(Date:8/23/2014)... The report “Polycarbonate Resin Market by Applications & ... and segments the global polycarbonate resin market with ... consumption. It also identifies driving and restraining factors ... of trends, opportunities, burning issues, winning imperatives. The ... forecasted on the basis of major regions such ...
Breaking Medicine News(10 mins):Health News:Dermatophytic Onychomycosis Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Health News:Dermatophytic Onychomycosis Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Health News:Dermatophytic Onychomycosis Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4Health News:Cardiomyopathy (Heart Muscle Disease) Therapeutics Clinical Trials Market 2014 Analysis in a New Report Available at MarketOptimizer.org 2Health News:Cardiomyopathy (Heart Muscle Disease) Therapeutics Clinical Trials Market 2014 Analysis in a New Report Available at MarketOptimizer.org 3Health News:Cardiomyopathy (Heart Muscle Disease) Therapeutics Clinical Trials Market 2014 Analysis in a New Report Available at MarketOptimizer.org 4Health News:Polycarbonate Resin Market by Applications and Geography Projected to $18.3 Billion by 2018 - New Report by MarketsandMarkets 2Health News:Polycarbonate Resin Market by Applications and Geography Projected to $18.3 Billion by 2018 - New Report by MarketsandMarkets 3Health News:Polycarbonate Resin Market by Applications and Geography Projected to $18.3 Billion by 2018 - New Report by MarketsandMarkets 4
... certain but solutions less so, experts say, , , FRIDAY, April 24 ... hard to avoid. But for people in stressful jobs, it,s especially ... protect the heart. , That,s because stress not only has ... but also a second. , "Work stress is bad for ...
... Hope Considered ,Too Important Not To Be Heard,SAN MATEO, ... that "Light of Hope: Help for Children with Autism," ... debut internationally on Friday, April 24, Saturday, April 25 ... during the final week of World Autism Awareness ...
... 2009 Annual Meeting of ShareholdersMCKINNEY, Texas, April 24 TORCHMARK CORPORATION (NYSE: ... 2009 Annual Meeting of Shareholders, When: ... Where: http://www.videonewswire.com/event.asp?id=56940 , How: ... at the, ...
... 24 Pharmatech Oncology, Inc., a Research Management ... launch of their Data Management business unit to ... Oncology Data Management business unit is branded as ... Data Management business unit maintains and processes data ...
... Copenhagen, Denmark, Friday 24 April: HIV positive and ... transplant, according to new research presented today at EASL ... the Study of Liver in Copenhagen, Denmark. , The ... 1 and 5 years between HIV negative and HIV ...
... HealthYes!™ is bringing its life-saving mobile screening services to ... most medically-advanced, state-of-the-art equipment and techniques to screen its ... abdominal aortic aneurysm, osteoporosis, and peripheral artery disease. ... ...
Cached Medicine News:Health News:Work Strife Stresses the Heart 2Health News:Work Strife Stresses the Heart 3Health News:'Light of Hope: Help for Children with Autism' Ground-Breaking Internet Television Event on April 24 to April 26 Co-Sponsored by Internet Software Leaders 2Health News:'Light of Hope: Help for Children with Autism' Ground-Breaking Internet Television Event on April 24 to April 26 Co-Sponsored by Internet Software Leaders 3Health News:Pharmatech Oncology Launches New Data Management Business Unit 2Health News:HIV positive and HIV negative patients have similar survival rates following liver transplant 2Health News:Texas-Based Mobile Health Screening Company Expands into Dallas-Fort Worth 2Health News:Texas-Based Mobile Health Screening Company Expands into Dallas-Fort Worth 3
Right angled 5 mm blunt hook. Overall length: 9.9 inches....
Fine short working end. Overall length: 4.9 inches. Most popular size or model....
11.5 mm curved hook. Flat serrated handle with polished finish. Overall length: 5.9 inches....
Designed for manipulating one piece lenses. The "Y: hook is excellent for capturing haptics and centering the lens. Straight shaft with "Y" shaped tip. Round knurled handle with dull finish. Overall ...
Medicine Products: